Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

John G. Stratton

At a glance: John G. Stratton is Director at Abbott Laboratories (ABT). Their latest SEC Form 4, filed Jun 18, 2026, reported a purchase of $174K. On file: 1 purchase line ($174K) and 0 sale lines ($0).

Disclosed holdings: about $2.4M of ABT stock: 23,319 shares reported on their latest Form 4 (filed Jun 18, 2026), valued at the Nov 20, 2026 close of $104.17. This counts only ABT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Abbott Laboratories (ABT)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+15.9%
vs. S&P 500+14.9%
Beat the market100%
Paper profit on buys+$35K
Total bought / sold$174K / $0

John G. Stratton's InsiderPrint

3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of John G. Stratton: 3 trades, 2020 to 20262020: 1 buy, 0 sales2021: 1 buy, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 1 buy, 0 sales

Reading this print: Almost only buys, trading about once a year, typically $174K a trade.

  • Bump outward: a purchase (3)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Jeffrey C. LightcapDirector · HTFL · 100% match
  2. Prithvi GandhiCFO · TREX · 99% match
  3. Lori WittmanDirector · AHRT · 99% match
  4. Beth J. KaplanDirector · CROX · 98% match
  5. Steven P. StanbrookDirector · PRMB · 98% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2026

From the SEC's insider data sets: each open-market buy by John G. Stratton, matched to how the stock did over the next 90 days against the S&P 500.

1 of 1 buy beat the S&P 500 (100%), median +15.6% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
ABTJun 18, 2026+15.6%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jun 18SEC ABTAbbott LaboratoriesFirst buy Buy 2,00023,319 held (+9%) $86.82 $174K +20.0%
  • Buy

    Director John G Stratton bought $174K of ABT at $86.82 — first open-market purchase in our records.

Follow John G. Stratton

Get one email when John G. Stratton files a new purchase or sale. Free.

At most one email a day about John G. Stratton, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.